Schedule 13G ownership disclosure

CYTOSORBENTS CORP

Common Stock, par value $0.001 per share · CUSIP: 23283X206

Event date: 2025-01-13

Filing-level shares
3,998,867.00
Percent of class
6.56%
  • Thomas A. Satterfield, Jr.

    Shares: 3,998,867.00 · Class: 6.56%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-004466
Form type
SCHEDULE 13G
Filer
Cytosorbents Corp
CIK
CIK 1175151
Filed
Jan 17, 2025
Reporting period
Jan 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub